Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform (2021)
Attributed to:
Understanding clusters and mechanisms of complex multimorbidity in people with common allergic conditions
funded by
SPF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.09.03.21262888
Publication URI: http://dx.doi.org/10.1101/2021.09.03.21262888
Type: Preprint